HRP960129B1 - NOVEL PYRIDO(3,2-e) PYRAZINONES WITH ANTIASTHMATIC ACTIVITY AND PROCESS FOR THEIR PREPARATION - Google Patents

NOVEL PYRIDO(3,2-e) PYRAZINONES WITH ANTIASTHMATIC ACTIVITY AND PROCESS FOR THEIR PREPARATION

Info

Publication number
HRP960129B1
HRP960129B1 HR960129A HRP960129A HRP960129B1 HR P960129 B1 HRP960129 B1 HR P960129B1 HR 960129 A HR960129 A HR 960129A HR P960129 A HRP960129 A HR P960129A HR P960129 B1 HRP960129 B1 HR P960129B1
Authority
HR
Croatia
Prior art keywords
pyrazinones
preparation
novel pyrido
antiasthmatic activity
antiasthmatic
Prior art date
Application number
HR960129A
Other languages
English (en)
Inventor
Norbert Hoefgen
Thomas Buechner
Ute Achterrath-Tuckermann
Stefan Szelenyi
Bernhard Kutscher
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of HRP960129A2 publication Critical patent/HRP960129A2/hr
Publication of HRP960129B1 publication Critical patent/HRP960129B1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pulmonology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR960129A 1995-03-24 1996-03-20 NOVEL PYRIDO(3,2-e) PYRAZINONES WITH ANTIASTHMATIC ACTIVITY AND PROCESS FOR THEIR PREPARATION HRP960129B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19510965A DE19510965A1 (de) 1995-03-24 1995-03-24 Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung

Publications (2)

Publication Number Publication Date
HRP960129A2 HRP960129A2 (en) 1997-08-31
HRP960129B1 true HRP960129B1 (en) 2002-12-31

Family

ID=7757727

Family Applications (1)

Application Number Title Priority Date Filing Date
HR960129A HRP960129B1 (en) 1995-03-24 1996-03-20 NOVEL PYRIDO(3,2-e) PYRAZINONES WITH ANTIASTHMATIC ACTIVITY AND PROCESS FOR THEIR PREPARATION

Country Status (30)

Country Link
US (1) US5723463A (pt)
EP (1) EP0736532B1 (pt)
JP (1) JP4124280B2 (pt)
KR (1) KR100401395B1 (pt)
CN (1) CN1058968C (pt)
AR (1) AR002039A1 (pt)
AT (1) ATE217624T1 (pt)
AU (1) AU697908B2 (pt)
BR (1) BR9601093A (pt)
CA (1) CA2172472C (pt)
CZ (1) CZ290784B6 (pt)
DE (2) DE19510965A1 (pt)
DK (1) DK0736532T3 (pt)
ES (1) ES2174989T3 (pt)
HR (1) HRP960129B1 (pt)
HU (1) HUP9600731A3 (pt)
IL (1) IL117621A (pt)
MX (1) MX9601069A (pt)
NO (1) NO307091B1 (pt)
NZ (1) NZ286232A (pt)
PL (1) PL184800B1 (pt)
PT (1) PT736532E (pt)
RU (1) RU2143433C1 (pt)
SG (1) SG43249A1 (pt)
SI (1) SI0736532T1 (pt)
SK (1) SK36596A3 (pt)
TR (1) TR199600217A2 (pt)
TW (1) TW426682B (pt)
UA (1) UA45319C2 (pt)
ZA (1) ZA962270B (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA200100792A1 (ru) * 1999-01-20 2002-10-31 Арцнаймиттельверк Дрезден Гмбх Применение имидазо[1,5-a]-пиридо[3,2-e]-пиразинонов в качестве лекарственных средств
DE19961302A1 (de) * 1999-12-18 2001-06-21 Dresden Arzneimittel Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen
PT1212089E (pt) 1999-08-21 2006-08-31 Altana Pharma Ag Combinacao sinergica de roflumilast e salmeterol
DE10012373A1 (de) * 2000-03-14 2001-09-20 Dresden Arzneimittel Verwendung von Pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erektiler Dysfunktion
US6465465B1 (en) 2000-03-14 2002-10-15 Arzneimittelwerk Dresden Gmbh Process for the treatment of erectile dysfunction and product therefor
JP2006522151A (ja) 2003-04-01 2006-09-28 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 不妊症におけるホスホジエステラーゼ阻害剤
GB0420722D0 (en) 2004-09-17 2004-10-20 Addex Pharmaceuticals Sa Novel allosteric modulators
AR059898A1 (es) 2006-03-15 2008-05-07 Janssen Pharmaceutica Nv Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2
TW200817400A (en) * 2006-05-30 2008-04-16 Elbion Ag Pyrido [3,2-e] pyrazines, their use as inhibitors of phosphodiesterase 10, and processes for preparing them
WO2008072779A1 (ja) * 2006-12-13 2008-06-19 Aska Pharmaceutical Co., Ltd. キノキサリン誘導体
TW200900065A (en) 2007-03-07 2009-01-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives
TW200845978A (en) * 2007-03-07 2008-12-01 Janssen Pharmaceutica Nv 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
AU2008297876B2 (en) 2007-09-14 2011-07-07 Addex Pharma S.A. 1,3-disubstituted 4-(aryl-x-phenyl)-1h-pyridin-2-ones
BRPI0816767B8 (pt) 2007-09-14 2021-05-25 Addex Pharmaceuticals Sa composto 4-fenil-3,4,5,6-tetra-hidro-2h,1'h-[1,4']bipiridi¬nil-2'-onas 1',3'-dissubstituídas, composição farmacêutica e uso dos mesmos
CN101801930B (zh) * 2007-09-14 2013-01-30 奥梅-杨森制药有限公司 1,3-二取代的-4-苯基-1h-吡啶-2-酮
ES2637794T3 (es) * 2007-11-14 2017-10-17 Janssen Pharmaceuticals, Inc. Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2
AU2008329072A1 (en) * 2007-11-30 2009-06-04 Elbion Gmbh Aryl and heteroaryl fused imidazo (1,5-A) pyrazines as inhibitors of phosphodiesterase 10
CA2706866A1 (en) 2007-11-30 2009-06-04 Biotie Therapies Gmbh Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10
AU2009289784B2 (en) 2008-09-02 2012-03-22 Addex Pharma S.A. 3-azabicyclo[3.1.0]hexyl derivatives as modulators of metabotropic glutamate receptors
WO2010043396A1 (en) 2008-10-16 2010-04-22 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
WO2010060589A1 (en) 2008-11-28 2010-06-03 Ortho-Mcneil-Janssen Pharmaceuticals, Inc. Indole and benzoxazine derivatives as modulators of metabotropic glutamate receptors
MY161325A (en) 2009-05-12 2017-04-14 Janssen Pharmaceuticals Inc 1, 2, 4-triazolo[4,3-a]pyridine derivatives and their use for the treatment or prevention of neurological and psychiatric disorders
US8946205B2 (en) 2009-05-12 2015-02-03 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
MY153913A (en) 2009-05-12 2015-04-15 Janssen Pharmaceuticals Inc 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors
PL2649069T3 (pl) 2010-11-08 2016-01-29 Janssen Pharmaceuticals Inc Pochodne 1,2,4-triazolo[4,3-a]pirydyny i ich zastosowanie jako dodatnich allosterycznych modulatorów receptorów mGluR2
CN103261195B (zh) 2010-11-08 2015-09-02 杨森制药公司 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途
AU2011328203B2 (en) 2010-11-08 2015-03-19 Janssen Pharmaceuticals, Inc. 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mGluR2 receptors
JO3368B1 (ar) 2013-06-04 2019-03-13 Janssen Pharmaceutica Nv مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2
JO3367B1 (ar) 2013-09-06 2019-03-13 Janssen Pharmaceutica Nv مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2
UA121965C2 (uk) 2014-01-21 2020-08-25 Янссен Фармацевтика Нв Комбінації, які містять позитивні алостеричні модулятори або ортостеричні агоністи метаботропного глутаматергічного рецептора 2 підтипу, та їх застосування
KR102461134B1 (ko) 2014-01-21 2022-10-28 얀센 파마슈티카 엔.브이. 대사 조절형 글루탐산 작동성 수용체 제2아형의 양성 알로스테릭 조절제 또는 오르토스테릭 작동제를 포함하는 조합 및 그 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166344A (en) * 1989-05-31 1992-11-24 Berlex Laboratories, Inc. Process for the preparation of imidazoquinoxalinones
US5055465A (en) * 1989-05-31 1991-10-08 Berlex Laboratories, Inc. Imidazoquinoxalinones, their aza analogs and process for their preparation
US5153196A (en) * 1991-06-05 1992-10-06 Eli Lilly And Company Excitatory amino acid receptor antagonists and methods for the use thereof
KR100207360B1 (ko) * 1991-06-14 1999-07-15 돈 더블유. 슈미츠 이미다조[1,5,-a]퀸옥살린
US5182386A (en) * 1991-08-27 1993-01-26 Neurogen Corporation Certain imidazoquinoxalinones; a new class of gaba brain receptor ligands
DE4228095A1 (de) * 1992-08-24 1994-03-03 Asta Medica Ag Neue 4,5-Dihydro-4-oxo-pyrrolo[1,2-a]chinoxaline und entsprechende Aza-analoga und Verfahren zu deren Herstellung
JP3252484B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 4,5−ジヒドロ[1,2,4]トリアゾロ[4,3−a]キノキサリン誘導体の製造方法
JP3252483B2 (ja) * 1992-10-20 2002-02-04 東レ株式会社 3環性トリアゾロ誘導体の製造方法
DE4329970A1 (de) * 1993-03-31 1994-10-06 Basf Ag Neue Imidazolo-chinoxalinone, ihre Hestellung und Verwendung
FR2704547B1 (fr) * 1993-04-30 1995-06-09 Adir Nouveaux composés pyrrolopyraziniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
WO1994026746A1 (en) * 1993-05-06 1994-11-24 Novo Nordisk A/S [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE
CA2112290C (en) * 1993-12-23 2004-06-01 John R. Francis A clock recovery circuit for serial digital video
JP3240462B2 (ja) * 1996-05-24 2001-12-17 株式会社ケンウッド 光ディスク装置の光ピックアップサーボ装置

Also Published As

Publication number Publication date
AU4825796A (en) 1996-10-03
IL117621A (en) 1999-05-09
NO961173D0 (no) 1996-03-22
EP0736532B1 (de) 2002-05-15
AU697908B2 (en) 1998-10-22
ES2174989T3 (es) 2002-11-16
JPH08269059A (ja) 1996-10-15
DE59609201D1 (de) 2002-06-20
SG43249A1 (en) 1997-10-17
KR960034204A (ko) 1996-10-22
KR100401395B1 (ko) 2003-12-24
CZ74796A3 (en) 1996-10-16
CA2172472A1 (en) 1996-09-25
JP4124280B2 (ja) 2008-07-23
ATE217624T1 (de) 2002-06-15
EP0736532A1 (de) 1996-10-09
PT736532E (pt) 2002-10-31
CN1058968C (zh) 2000-11-29
NO961173L (no) 1996-09-25
US5723463A (en) 1998-03-03
CN1140173A (zh) 1997-01-15
SK36596A3 (en) 1997-02-05
AR002039A1 (es) 1998-01-07
HRP960129A2 (en) 1997-08-31
DE19510965A1 (de) 1996-09-26
HUP9600731A3 (en) 1997-04-28
CZ290784B6 (cs) 2002-10-16
HUP9600731A2 (en) 1997-01-28
IL117621A0 (en) 1996-07-23
PL313434A1 (en) 1996-09-30
TW426682B (en) 2001-03-21
ZA962270B (en) 1996-09-30
BR9601093A (pt) 1998-01-06
CA2172472C (en) 2000-01-18
DK0736532T3 (da) 2002-09-02
NZ286232A (en) 1996-10-28
HU9600731D0 (en) 1996-05-28
NO307091B1 (no) 2000-02-07
TR199600217A2 (tr) 1996-10-21
SI0736532T1 (en) 2002-08-31
RU2143433C1 (ru) 1999-12-27
UA45319C2 (uk) 2002-04-15
MX9601069A (es) 1997-02-28
PL184800B1 (pl) 2002-12-31

Similar Documents

Publication Publication Date Title
HRP960129B1 (en) NOVEL PYRIDO(3,2-e) PYRAZINONES WITH ANTIASTHMATIC ACTIVITY AND PROCESS FOR THEIR PREPARATION
HU9402076D0 (en) Pyrido[2,3-a]-pyridazin-5-one and pyrido[2,3a]-pyridiazin-5-thione derivatives, process for thein preparation and compositions containing them
AU3593393A (en) Process for the preparation of D(-) and L(+)-3,3-diphenylalanine and D(-) and L(+)-substituted 3,3-diphenylalanines and derivatives thereof
AU3788189A (en) 3, 9-diphosphaspiroundecanes and process for making3, 9-diphosphaspiroundecanes
EP0584487A3 (en) 4,5-dihydro-4-oxopyrrolo (1,2-a) quinoxalines and aza-analoges and process for their preparation
IL104706A0 (en) 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-ones and process for the preparation thereof
HK1010885A1 (en) 10,13,15-trioxatricyclo [9.2.1.1.9.6]-pentadecanone-derivatives, process for their preparation and pharmaceutical containing them
AU8135191A (en) Hydrogenated pyridine and imidax-(1,5-a)pyridine derivatives
AU1301797A (en) Polypeptides with interleukin 16 activity, process for the preparation and use thereof
AU4926190A (en) 2,3,23-trihydroxy-urs-12-ene and its derivatives, processes for their preparation and their use
AU639825B2 (en) Substituted 1,2,4-triazinediones, processes for their preparation, intermediates therefor and their use
HUP9600665A2 (en) Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation
AU4172693A (en) Novel thienothiazine derivatives, process for their preparation and their use
ZA9786B (en) 5H 10h-imidazo [1,2-a]indeno[1,2-e] pyrazin-4-one derivatives their preparation their intermediates and medicaments containing them
AU3744495A (en) Process for preparing 1,3-alkanediols and 3-hydroxyldehydes
AU9139591A (en) Process for the preparation of bromonitro-alcohols, dibromonitro-alcohols and blends thereof
AU6118090A (en) N,n'-bis-1,3,5-triazin-6-ylpiperazines, and process for their preparation
IL123793A (en) 1,1 - difluoro - 1,4 - dichlorobutane and process for its preparation
GB9400302D0 (en) Flocculation-stable pigments, processes for their preparation and their use
EP0778278B1 (de) Alkoxyformoxysilane, ein Verfahren zu ihrer Herstellung sowie ihre Verwendung
HUP9700628A3 (en) 4-thia-1-aza-bicyclo[3.2.0]heptan-3-imino-2-izopropiliden-7-oxo-beta-lactame derivatives, process for producing them and use of them
AU5390790A (en) Tetrahydroisoquino (2,1-c)(1,3)benzodiazepines, a process for their preparation and their use as medicaments
HU9700366D0 (en) Novel derivatives of 3-bromo- and 3,3 dibromo-4-oxo-1-azetidines, process for the preparation thereof and their use
GB9314488D0 (en) 2,2'-dipyrromethene derivatives and process for their preparation
GB2273096B (en) Piperido (4',3':16,17)-4-Aza-5alpha-androstan-3-one derivatives and process for their preparation

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20030314

Year of fee payment: 8

PBON Lapse due to non-payment of renewal fee

Effective date: 20040321